AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
14.05
+0.34 (2.48%)
Jul 21, 2026, 1:44 PM EDT - Market open
AngioDynamics Revenue
In the fiscal year ending May 31, 2026, AngioDynamics had annual revenue of $320.17M with 9.46% growth. AngioDynamics had revenue of $86.61M in the quarter ending May 31, 2026, with 8.05% growth.
Revenue (ttm)
$320.17M
Revenue Growth
+9.46%
P/S Ratio
1.81
Revenue / Employee
$506,604
Employees
632
Market Cap
580.72M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2026 | 320.17M | 27.68M | 9.46% |
| May 31, 2025 | 292.50M | -11.42M | -3.76% |
| May 31, 2024 | 303.91M | -34.84M | -10.28% |
| May 31, 2023 | 338.75M | 22.53M | 7.13% |
| May 31, 2022 | 316.22M | 25.21M | 8.66% |
| May 31, 2021 | 291.01M | 26.85M | 10.17% |
| May 31, 2020 | 264.16M | -6.48M | -2.39% |
| May 31, 2019 | 270.63M | 8.98M | 3.43% |
| May 31, 2018 | 261.66M | -8.13M | -3.01% |
| May 31, 2017 | 269.79M | -84.10M | -23.77% |
| May 31, 2016 | 353.89M | -2.64M | -0.74% |
| May 31, 2015 | 356.53M | 2.11M | 0.60% |
| May 31, 2014 | 354.43M | 12.51M | 3.66% |
| May 31, 2013 | 341.92M | 120.00M | 54.07% |
| May 31, 2012 | 221.92M | 6.17M | 2.86% |
| May 31, 2011 | 215.75M | -285.00K | -0.13% |
| May 31, 2010 | 216.04M | 20.98M | 10.76% |
| May 31, 2009 | 195.05M | 28.55M | 17.15% |
| May 31, 2008 | 166.50M | 54.27M | 48.36% |
| Jun 2, 2007 | 112.23M | 33.78M | 43.05% |
| Jun 3, 2006 | 78.45M | 18.16M | 30.12% |
| May 28, 2005 | 60.29M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Embecta | 1.04B |
| Azenta | 596.48M |
| STAAR Surgical Company | 290.38M |
| OraSure Technologies | 113.02M |
| Sanara MedTech | 107.48M |
| BioLife Solutions | 101.66M |
| Kestra Medical Technologies | 95.13M |
| KORU Medical Systems | 43.26M |
ANGO News
- 1 day ago - 3 Small-Cap Stocks with ‘Strong Buy’ Ratings and 40%+ Upside, According to Analysts - TipRanks
- 6 days ago - AngioDynamics price target raised to $19 from $16 at H.C. Wainwright - TheFly
- 6 days ago - AngioDynamics price target raised to $20 from $16 at Canaccord - TheFly
- 7 days ago - AngioDynamics Earnings Call Transcript: Q4 2026 - Transcripts
- 7 days ago - AngioDynamics Earnings release: Q4 2026 - Filings
- 7 days ago - AngioDynamics Slides: Q4 2026 - Filings
- 7 days ago - AngioDynamics Annual report: Q4 2026 - Filings
- 7 days ago - AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability - Business Wire